GL1X · GenesisL1 explorer

MolNFT v1 · #26419 · protein

Crystal structure of SARS-cov mpro in complex with an inhibitor N1

1WOF · 3C-like proteinase: “Crystal structure of SARS-cov mpro in complex with an inhibitor N1”. X-ray diffraction, 1 ligand (I12), 6 pockets (best druggability 0.77). MolNFT v1 #26419 on GenesisL1: 3D structure, binding sites and pockets…

PDB
1WOF
Type
protein
Length
613 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.24.-
UniProt
P59641
Ligands
I12
Pockets
6 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.24.-)protein30926% helix, 28% strandP59641
B3C-like proteinase (EC 3.4.24.-)protein30425% helix, 30% strandP59641

Ligands and binding sites

  • I12 · N-[(5-methylisoxazol-3-yl)carbonyl]-L-alanyl-L-valyl-N~1~-((1S)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18680.770.8172empty
24820.610.7572empty
32090.540.7832I12
41880.530.7830I12
51890.520.7731empty

Interfaces

1 interface between chains.

  • A–B · 1519 Ų buried · 40 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1WOF · Crystal Structure Of SARS-CoV Mpro in Complex with an Inhibitor N1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.